On April 13, 2026, at the launch ceremony of the CACA Discipline Empowerment Co-building Unit Initiative during the 2026 National Cancer Prevention and Treatment Awareness Week, Guangzhou First People’s Hospital and Modern Cancer Hospital Guangzhou officially signed a specialty alliance cooperation agreement. The two parties will jointly establish a hematology ward at Modern Cancer Hospital Guangzhou, leveraging the top-tier diagnosis and treatment expertise in blood diseases from Guangzhou First People’s Hospital and the well-established international service platform of Modern Cancer Hospital Guangzhou. This collaboration aims to create a new“one-stop”high-quality medical option for patients with blood diseases from both China and abroad.

Top Specialty and International Services Join Hands

The Department of Hematology at Guangzhou First People’s Hospital is a National Key Clinical Specialty, a Guangzhou Key Medical Discipline, a Guangdong Provincial High-Level Key Clinical Specialty, and a training base for hematopoietic stem cell transplantation technology in Guangdong Province. Established in 1974, the department is nationally renowned for its expertise in the diagnosis and treatment of aplastic anemia. Its allogeneic hematopoietic stem cell transplantation technique for severe aplastic anemia has been recognized as a Guangzhou Clinical Advanced Technology, and the department’s annual transplant volume ranks among the highest in China.

Modern Cancer Hospital Guangzhou, on the other hand, has been deeply engaged in international medical services for over 20 years. As a China Anti-Cancer Association“Belt and Road”International Training Center for Integrative Oncology, its service network covers nearly 100 countries and regions across Southeast Asia, South Asia, Central Asia, and beyond, having treated over 100,000 international cancer patients to date. The hospital holds JCI international accreditation for its standardized quality management system and has accumulated extensive experience in overseas patient services, multilingual support, and cross-border medical referrals, making it a highly influential international oncology hospital in South China.

Technology Export + International Platform: Achieving Complementary Advantages

Under the agreement, the two parties will jointly establish a hematology ward at Modern Cancer Hospital Guangzhou. Modern Cancer Hospital Guangzhou will provide advanced hardware facilities and an international service environment, while Guangzhou First People’s Hospital will station a team of leading hematology experts to jointly formulate diagnosis and treatment plans and administer care for patients. This model achieves a precise integration of“cutting-edge technology”and“international access”:

For both hospitals: Guangzhou First People’s Hospital expands its reach in serving international patients, while Modern Cancer Hospital Guangzhou deepens its clinical expertise in hematology, achieving disciplinary complementarity.

For patients: They will not only have access to the diagnosis and treatment techniques for blood diseases from a national key clinical specialty, but also enjoy the full range of services tailored by Modern Cancer Hospital Guangzhou for overseas patients, including convenient cross-border medical care—truly delivering a“worry-free treatment experience in China”.

Responding to Medical Tourism Trends and Fulfilling the Mission of the CACA Training Center

This cooperation represents not only a concrete action by Modern Cancer Hospital Guangzhou to respond to the city’s encouragement of medical tourism development and to enhance its international service capabilities, but also a fulfillment of its mission as a China Anti-Cancer Association International Training Center for Integrative Oncology to promote the dissemination of advanced medical technologies and build international academic bridges. Through this specialty alliance, China’s advanced diagnosis and treatment technologies for blood diseases will reach more conveniently to patients in need along the Belt and Road countries and beyond.

Bringing China’s Blood Disease Diagnosis and Treatment Expertise to the World

Through this alliance, the two parties will start with the hematology ward and gradually expand to deeper levels of cooperation in areas such as clinical research on cell and gene therapy, training of overseas physicians, and telemedicine consultations.

From a“hub for aplastic anemia diagnosis and treatment”to an“international medical hub”, the partnership between Guangzhou First People’s Hospital and Modern Cancer Hospital Guangzhou represents not only an optimized allocation of medical resources but also a cross-border commitment to health. Let us look forward to the early opening of the sterile hematology ward, giving patients long afflicted by blood diseases in Southeast Asia, South Asia, and beyond the opportunity to reignite their hope for life in Guangzhou.